Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
Miles A. Miller(Harvard University), Ralph Weissleder(Harvard University), Yoshiko Iwamoto(Harvard University), Bjorn Askevold(Harvard University), Rainer H. Köhler(Massachusetts General Hospital), Stephen J. Lippard(Massachusetts Institute of Technology), Nagesh Kolishetti(Brigham and Women's Hospital), Yao‐Rong Zheng(Kent State University), Omid C. Farokhzad(Brigham and Women's Hospital), Christina Pfirschke(Harvard University), Katherine S. Yang(Bioanalytica (Switzerland)), Suresh Gadde(University of Ottawa), Mikaël J. Pittet(University of Geneva), Camilla Engblom(Karolinska Institutet), Harshal Zope(Brigham and Women's Hospital)
Cited by 435
Related Papers
Cancer nanomedicine: progress, challenges and opportunities
|Nature reviews. Cancer|2016|5.6k
A clearer vision for in vivo imaging
|Nature Biotechnology|2001|3.8k
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
|Chemical Reviews|2016|2.4k
Imaging in the era of molecular oncology
|Nature|2008|2.3k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k